Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free

Flotek Industries Shares Surge 17.2% as Q3 Revenue Doubles and Company Raises 2026 Guidance

By Fiona Craig | November 04, 2026, 8:43 AM

Flotek Industries (NYSE:FTK) shares surged 17.2% to $29.11 in premarket trading on Wednesday after the energy technology company reported stronger-than-expected third-quarter 2026 results, with revenue more than doubling from a year earlier and earnings exceeding Wall Street forecasts.

The company generated quarterly revenue of $114.4 million, its highest level in 12 years, representing a 104% increase compared with the same period in 2025. Earnings per share reached $0.34, surpassing analyst expectations of $0.21.

Flotek also raised its full-year revenue and adjusted EBITDA forecasts, supported by growth across its Chemistry Technologies and Data Analytics businesses and a substantial increase in international sales.

The results, released following Monday’s market close, prompted strong buying interest in after-hours and premarket trading.

Third-Quarter Revenue Climbs 104% to $114.4 Million

Flotek reported its strongest quarterly revenue performance in more than a decade, reflecting substantial expansion across its principal business segments.

Revenue increased 104% year over year to $114.4 million, marking the company’s highest quarterly total in 12 years.

The results demonstrated significant growth compared with the corresponding period of 2025, supported by demand for the company’s energy-related chemical technologies and data analytics services.

Earnings per share of $0.34 exceeded the Wall Street consensus estimate of $0.21 by $0.13, representing a substantial earnings surprise.

The stronger-than-expected performance reinforced investor confidence in Flotek’s operating strategy and its ability to generate growth across multiple business areas.

The company also reported that revenue, net income and adjusted EBITDA had increased in each quarter of 2026, highlighting the consistency of its financial improvement throughout the year.

Chemistry Technologies and Data Analytics Both Deliver 104% Growth

Growth was broad-based across Flotek’s operations, with both its Chemistry Technologies and Data Analytics segments recording substantial year-over-year revenue increases.

Each business reported revenue growth of 104% compared with the third quarter of 2025.

The Chemistry Technologies division benefited from expanding demand for its chemical solutions, including increased international activity.

Meanwhile, the Data Analytics business continued to contribute to the company’s overall growth, reflecting demand for technology and analytical services within the energy industry.

The similar growth rates across both segments indicated that Flotek’s revenue expansion was not dependent on a single business line.

This diversification provided additional support for management’s decision to increase its full-year financial expectations.

International Chemistry Revenue Jumps to $28.4 Million

International operations were a particularly important contributor to Flotek’s third-quarter performance.

Revenue from the company’s international Chemistry business increased to $28.4 million, compared with $2.2 million in the corresponding period of 2025.

The sharp increase reflected accelerating demand from customers in the Middle East, where Flotek has been expanding its commercial activities.

The region’s contribution demonstrated the potential importance of international markets to the company’s longer-term growth strategy.

Expansion outside the United States can provide additional revenue opportunities, although it may also introduce risks related to project timing, customer concentration and regional market conditions.

The substantial increase in international Chemistry revenue was one of the principal factors supporting Flotek’s stronger quarterly results.

Investors will be monitoring whether demand from the Middle East continues to support revenue growth in subsequent quarters.

Adjusted EBITDA Nearly Doubles to $19.5 Million

Flotek also reported a significant improvement in adjusted operating profitability.

Third-quarter adjusted EBITDA increased to $19.5 million from $10.4 million in the same period last year, representing growth of approximately 87.5%.

The increase demonstrated that the company was generating stronger adjusted earnings alongside its substantial revenue expansion.

Higher revenue can support operating leverage when a company’s costs increase at a slower rate than sales.

Flotek’s adjusted EBITDA performance suggested that its expanding business operations were contributing to improved profitability on this measure.

However, adjusted EBITDA excludes certain expenses and should be considered alongside GAAP net income and other financial indicators when assessing the company’s overall performance.

The company also recorded a year-over-year decline in GAAP net income, which was largely attributed to a one-time, non-cash tax benefit recognised during the third quarter of 2025.

That prior-year benefit affected the comparison between the two periods, despite the improvement in revenue and adjusted EBITDA during the latest quarter.

Flotek Raises Full-Year Revenue Forecast to $382 Million–$390 Million

Following the stronger quarterly performance, Flotek increased its revenue guidance for the full year of 2026.

Management now expects annual revenue of between $382 million and $390 million, compared with its previous forecast of $360 million to $370 million.

The revised guidance represents an increase of $22 million at the lower end and $20 million at the upper end of the range.

At the midpoint, the new forecast implies annual revenue of approximately $386 million, compared with $365 million under the previous outlook.

The increase reflects management’s confidence in the company’s operating momentum and expectations for continued demand across its business segments.

It also marks the second consecutive quarterly increase in Flotek’s financial guidance.

The repeated upward revisions have reinforced investor expectations that the company can maintain its recent growth trajectory through the remainder of 2026.

Adjusted EBITDA Guidance Increased to $59 Million–$62 Million

Flotek also raised its full-year adjusted EBITDA forecast, reflecting stronger profitability expectations.

The company now anticipates adjusted EBITDA of between $59 million and $62 million for 2026, compared with its previous guidance of $50 million to $54 million.

The revised range represents an increase of $9 million at the lower end and $8 million at the upper end.

At the midpoint, the new outlook implies adjusted EBITDA of $60.5 million, compared with $52 million previously.

The higher forecast follows the company’s third-quarter adjusted EBITDA of $19.5 million and reflects expectations for continued operating performance during the final months of the year.

The simultaneous increases in revenue and adjusted EBITDA guidance suggest that management anticipates continued growth in both sales and adjusted profitability.

For investors, the improved outlook was a significant factor behind Wednesday’s premarket rally.

Corporate Filings Accompany Earnings Announcement

Flotek’s latest financial results were formally disclosed through a Form 8-K filing with the US Securities and Exchange Commission on November 3.

The filing documented the company’s earnings announcement and related corporate disclosures.

A separate Form 4 filing involving the company’s chief executive officer also formed part of the recent corporate reporting activity.

Form 4 filings are used to disclose certain transactions involving company insiders, although the information provided did not specify the nature or size of the transaction.

Investors may review these disclosures alongside the financial results when assessing the company’s recent developments.

The earnings announcement remained the principal identified catalyst for the sharp increase in Flotek’s share price.

Flotek Outperforms Broader US Stock Market

Flotek’s 17.2% premarket gain substantially exceeded the advances recorded across major US equity indexes.

During the same period, the S&P 500 rose 0.6%, while the Dow Jones Industrial Average gained 1.0% and the Nasdaq advanced 0.5%.

The broader market’s positive performance provided a supportive trading environment, but the scale of Flotek’s rally indicated that company-specific developments were the primary driver.

Ahead of the earnings announcement, Flotek had already received a Strong Buy consensus rating from analysts, with the average price target reportedly above its recent trading levels.

The stronger-than-expected results and increased guidance provided additional support for the positive outlook.

However, the stock’s future performance will depend on the company’s ability to deliver against its revised forecasts and sustain its recent operating improvements.

Earnings Call Expected to Provide Further Details

Flotek scheduled its third-quarter earnings conference call for 9:00 a.m. Central Time on Wednesday.

The discussion is expected to provide investors with additional information about the company’s quarterly performance and updated financial expectations.

Particular attention is likely to focus on the sustainability of international revenue growth, especially the substantial increase in Chemistry Technologies sales from the Middle East.

Management may also provide further details about demand trends, operating margins and the assumptions supporting the revised revenue and adjusted EBITDA guidance.

Investors will be assessing whether the company’s recent growth can continue into the final quarter of 2026 and beyond.

The conference call could therefore provide additional context for the market’s positive reaction to the earnings announcement.

Shares Recover Following Decline From 52-Week High

Wednesday’s premarket rally followed a period of weakness in Flotek shares.

The stock had previously retreated substantially from its reported 52-week high of $39.67.

At the premarket price of $29.11, Flotek remained approximately 26.6% below that high despite its 17.2% advance.

The sharp increase indicated that investors were reassessing the company’s valuation following its stronger financial performance and improved annual outlook.

The recovery also reflected renewed confidence in Flotek’s ability to benefit from international expansion and growth across its core business segments.

However, the sustainability of the rally will depend on continued execution and whether future results support the company’s higher financial expectations.

Outlook for Flotek Industries

Flotek Industries enters the final quarter of 2026 with strong operating momentum following a substantial increase in revenue and adjusted profitability.

Third-quarter revenue of $114.4 million represented 104% annual growth, while earnings per share of $0.34 exceeded analyst expectations.

The company’s international Chemistry operations delivered particularly strong performance, with revenue increasing to $28.4 million from $2.2 million a year earlier.

Adjusted EBITDA also improved significantly to $19.5 million, supporting management’s decision to raise its full-year revenue guidance to $382 million–$390 million and adjusted EBITDA expectations to $59 million–$62 million.

The improved forecasts, combined with consistent quarterly growth throughout 2026, have strengthened investor sentiment and contributed to the 17.2% premarket increase.

Investors will now be monitoring the company’s ability to sustain international demand, maintain adjusted profitability and achieve its revised financial targets.

The upcoming management discussion and subsequent operating results will provide further evidence of whether Flotek can maintain its recent growth trajectory.

Flotek Industries stock price

Mentioned In This Article

Latest News

Nov-04
Nov-04
Nov-03
Nov-03
Oct-26
Oct-26
Oct-26
Oct-20
Oct-15
Oct-14
Oct-13
Oct-12
Sep-30
Sep-23
Sep-21